US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

AERO TAB Cold Relief

Reason cGMP deviations

Ultra Seal Corporation D-0466-2022
Class II · Moderate risk Terminated

Nasal & Sinus Decongestant

Reason cGMP deviations

Ultra Seal Corporation D-0464-2022
Class II · Moderate risk Terminated

Proctofoam HC

Reason cGMP deficiencies

Mylan Pharmaceuticals Inc NDC 0037-6822-10 D-0452-2022
Class III · Low risk Terminated

Bortezomib

Reason Failed stability specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-865-60 D-0577-2022
Class III · Low risk Terminated

Azacitidine

Reason Failed stability specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-465-62 D-0576-2022
Class III · Low risk Terminated

Azacitidine

Reason Failed stability specifications

Dr. Reddy's Laboratories, Inc. NDC 43598-305-62 D-0575-2022
Class II · Moderate risk Terminated

Moxifloxacin Ophthalmic Solution

Reason Failed Impurities/Degradation Specifications

Aurobindo Pharma USA Inc. NDC 65862-840-03 D-0560-2022
Class II · Moderate risk Ongoing

Lexette

Reason CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

Mayne Pharma Inc NDC 51862-604-50 D-0387-2022
Class II · Moderate risk Terminated

Lung Cleaner

Reason cGMP deviations

Pharmasol Corporation D-0574-2022
Class II · Moderate risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Lack of Assurance of Sterility

Exela Pharma Sciences LLC NDC 51754-5001-1 D-0369-2022
Class II · Moderate risk Terminated

Tretinoin Capsules

Reason Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

Teva Pharmaceuticals USA NDC 0555-0808-02 D-0520-2022
Class III · Low risk Terminated

Mucus Relief D

Reason Subpotent drug

Dr. Reddy's Laboratories, Inc. NDC 0363-164-3 D-0388-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Foam

Reason CGMP Deviations

Ingenus Pharmaceuticals Llc NDC 50742-304-50 D-0374-2022
Class III · Low risk Terminated

Mimvey

Reason Mislabeling

Teva Pharmaceuticals USA NDC 0093-5455-42 D-0522-2022
Class III · Low risk Terminated

Mimvey

Reason Mislabeling

Teva Pharmaceuticals USA NDC 0093-5455-28 D-0521-2022
Class II · Moderate risk Terminated

Clobazam Oral Suspension 2.5 mg/mL

Reason Failed Stability Specifications

VistaPharm, Inc. NDC 66689-058-04 D-0376-2022
Class I · High risk Terminated

Semglee

Reason Labeling: Missing Label: label missing from some Semglee prefilled pens.

Mylan Pharmaceuticals Inc NDC 49502-0196-71 D-0462-2022
Class II · Moderate risk Terminated

Sufentanil Citrate Injection

Reason Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.

Akorn, Inc. NDC 17478-0050-02 D-0460-2022
Class III · Low risk Terminated

Leader

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. NDC 70000-0518-1 D-0386-2022
Class III · Low risk Terminated

CVS Health

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. D-0385-2022
Class III · Low risk Terminated

Qc Quality Choice

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. NDC 63868-729-10 D-0384-2022
Class III · Low risk Terminated

equate

Reason Failed Dissolution Specifications

Dr. Reddy's Laboratories, Inc. NDC 49035-273-20 D-0383-2022